950577-05-6 Usage
Uses
Used in Pharmaceutical Industry:
6-bromo-7-methoxy-4(3H)-Quinazolinone is used as a potential therapeutic agent for various conditions due to its demonstrated biological activities. Its antifungal properties make it a candidate for treating fungal infections, while its anti-inflammatory effects could be beneficial in managing inflammatory diseases.
Used in Antitubercular Applications:
6-bromo-7-methoxy-4(3H)-Quinazolinone is used as an antitubercular agent, showing promise in the development of new treatments for tuberculosis. Its potential to target and combat the causative agent of tuberculosis positions BQ as a valuable compound in the ongoing fight against this infectious disease.
Used in Drug Discovery and Development:
6-bromo-7-methoxy-4(3H)-Quinazolinone is used as a subject of research in drug discovery and development. Its unique structure and pharmacological activities make it an interesting candidate for further exploration and potential incorporation into new medications for a variety of health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 950577-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,5,7 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 950577-05:
(8*9)+(7*5)+(6*0)+(5*5)+(4*7)+(3*7)+(2*0)+(1*5)=186
186 % 10 = 6
So 950577-05-6 is a valid CAS Registry Number.
950577-05-6Relevant academic research and scientific papers
BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE
-
Page/Page column 198, (2012/06/15)
The invention is directed 10 Compound's of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
-
Page/Page column 190, (2010/12/18)
The invention is directed to compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
SULPHOXIMINE-SUBSTITUTED QUINAZOLINE DERIVATIVES AS IMMUNO-MODULATORS, THEIR PREPARATION AND USE AS MEDICAMENTS
-
Page/Page column 39-40, (2009/07/25)
The present invention relates to sulphoximine-substituted quinazoline derivatives of the formula (I), processes for their preparation and their use as a medicament for the treatment of various diseases.
Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof
-
Page/Page column 68, (2009/04/24)
Substituted 4-amino-quinazoline compounds corresponding to formula I methods for their production, pharmaceutical compositions containing these compounds as active agents, and the uses thereof for treating or inhibiting disorders or disease states.
